Haemophilic synovitis: is rifampicin an alternative?

Rifampicin synoviorthesis has been empirically used for the treatment of haemophilic synovitis for some time. This paper reports on the experience of three Latin American centers with this treatment and compares it with radioactive synoviorthesis results. Chemical synoviorthesis with rifampicin is b...

Full description

Saved in:
Bibliographic Details
Published in:Haemophilia : the official journal of the World Federation of Hemophilia 1998-07, Vol.4 (4), p.514-517
Main Authors: Lee, C. A., Kessler, C. M., Varon, D., Martinowitz, U., Heim, M., CAVIGLIA, H., GALATRO, G., DUHALDE, C., PEREZ-BIANCO, R.
Format: Article
Language:English
Subjects:
chemical synoviorthesis
Haemophilia
Hemophilia A - complications
Hemophilia A - pathology
Hemophilia A - physiopathology
Humans
Nucleic Acid Synthesis Inhibitors - therapeutic use
rifampicin
Rifampin - therapeutic use
synovitis
Synovitis - drug therapy
Synovitis - etiology
Synovitis - physiopathology
Synovitis - surgery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rifampicin synoviorthesis has been empirically used for the treatment of haemophilic synovitis for some time. This paper reports on the experience of three Latin American centers with this treatment and compares it with radioactive synoviorthesis results. Chemical synoviorthesis with rifampicin is best indicated in younger patients (
ISSN:1351-8216
1365-2516
DOI:10.1046/j.1365-2516.1998.440514.x